Work

Improving the Quality of Decision-Making Processes for Prostate Cancer Screening: Progress and Challenges

Year: 2013

Type: article

Abstract: Guidelines recommend that patients be informed about potential benefits and harms from prostate cancer screening and that screening decisions involve a discussion between patients and their physicians.1,2Despite this consensus, achieving high-quality decision-making processes in practice is difficult.Clinicians function in a time-constrained environment and know that ordering a prostate-specific antigen (PSA) blood test is simple, whereas ensuring that patients fully understand the potential ramifications of entering a screening program is far more difficult and time-consuming.Explaining such concepts as biopsy threshold, falsepositive results, overdiagnosis, and uncertainty about magnitude of benefit is challenging and cannot be done quickly.

Source: JAMA Internal Medicine

DOI: 10.1001/jamainternmed.2013.6561

Authors: Daniel S. Reuland, Michael Pignone

Institutions: University of North Carolina at Chapel Hill, University of North Carolina Hospitals, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Patient-Provider Communication in Healthcare

Subfield: General Health Professions

Field: Health Professions

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Informed Medical Decisions Foundation, National Cancer Institute